On Tuesday, Summit Therapeutics' Chief Financial Officer, Ankur Dhingra, made a $375,000 buy of SMMT, purchasing 100,000 shares at a cost of $3.75 each. So far Dhingra is in the green, up about 23.7% on their buy based on today's trading high of $4.64. Summit Therapeutics is trading up about 13.1% on the day Thursday. Before this latest buy, Dhingra made one other buy in the past twelve months, purchasing $44,254 shares at a cost of $2.17 each.
And on Wednesday, Chief Executive Officer Jason Stabell bought $191,446 worth of Epsilon Energy, buying 36,466 shares at a cost of $5.25 each. Before this latest buy, Stabell purchased EPSN at 5 other times during the past year, for a total investment of $1.6M at an average of $4.92 per share. Epsilon Energy is trading up about 2.3% on the day Thursday.
VIDEO: Thursday 3/28 Insider Buying Report: SMMT, EPSN
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
